×




Olam: Accounting for Biological Assets Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Olam: Accounting for Biological Assets case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Olam: Accounting for Biological Assets case study is a Harvard Business School (HBR) case study written by Yew Kee Ho, Teo Chee Khiang, Sitoh Kheng Hoe. The Olam: Accounting for Biological Assets (referred as “Olam Biological” from here on) case study provides evaluation & decision scenario in field of Finance & Accounting. It also touches upon business topics such as - Value proposition, International business.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Olam: Accounting for Biological Assets Case Study


In 2012, an equity research firm based in California accused Singapore-based Olam International Limited (Olam) of engaging in potentially misleading and dangerous accounting practices. The firm - Muddy Waters Research - further stated that Olam was on the verge of bankruptcy. The primary complaint made against Olam by Muddy Waters was that Olam allegedly made aggressive use of "non-cash accounting gains," particularly when reporting on Olam's biological assets. Olam's share price tumbled after the accusations were made public. Olam defended itself by asserting that it had applied Singapore Financial Reporting Standard (FRS) 41 - Agriculture appropriately and that the fair value gains of the biological assets were justifiably derived. FRS 41, equivalent to International Financial Accounting Standards 41 - Agriculture, required Singapore-listed companies to use fair value in the measurement of biological assets. This case examines the complex challenges that valuators face when presented with different valuation models, the application of financial reporting standards and the fine balance between reliability and relevance in the accounting of assets in the real world. Yew Kee Ho is affiliated with National University of Singapore.


Case Authors : Yew Kee Ho, Teo Chee Khiang, Sitoh Kheng Hoe

Topic : Finance & Accounting

Related Areas : International business




Calculating Net Present Value (NPV) at 6% for Olam: Accounting for Biological Assets Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10020366) -10020366 - -
Year 1 3456970 -6563396 3456970 0.9434 3261292
Year 2 3957182 -2606214 7414152 0.89 3521878
Year 3 3957640 1351426 11371792 0.8396 3322911
Year 4 3234206 4585632 14605998 0.7921 2561794
TOTAL 14605998 12667875




The Net Present Value at 6% discount rate is 2647509

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Net Present Value
2. Payback Period
3. Internal Rate of Return
4. Profitability Index

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Timing of the expected cash flows – stockholders of Olam Biological have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.
2. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Olam Biological shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.






Formula and Steps to Calculate Net Present Value (NPV) of Olam: Accounting for Biological Assets

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Finance & Accounting Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Olam Biological often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Olam Biological needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10020366) -10020366 - -
Year 1 3456970 -6563396 3456970 0.8696 3006061
Year 2 3957182 -2606214 7414152 0.7561 2992198
Year 3 3957640 1351426 11371792 0.6575 2602213
Year 4 3234206 4585632 14605998 0.5718 1849168
TOTAL 10449639


The Net NPV after 4 years is 429273

(10449639 - 10020366 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10020366) -10020366 - -
Year 1 3456970 -6563396 3456970 0.8333 2880808
Year 2 3957182 -2606214 7414152 0.6944 2748043
Year 3 3957640 1351426 11371792 0.5787 2290301
Year 4 3234206 4585632 14605998 0.4823 1559706
TOTAL 9478858


The Net NPV after 4 years is -541508

At 20% discount rate the NPV is negative (9478858 - 10020366 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Olam Biological to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Olam Biological has a NPV value higher than Zero then finance managers at Olam Biological can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Olam Biological, then the stock price of the Olam Biological should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Olam Biological should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What can impact the cash flow of the project.

What will be a multi year spillover effect of various taxation regulations.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

Understanding of risks involved in the project.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Olam: Accounting for Biological Assets

References & Further Readings

Yew Kee Ho, Teo Chee Khiang, Sitoh Kheng Hoe (2018), "Olam: Accounting for Biological Assets Harvard Business Review Case Study. Published by HBR Publications.


Skipper Ltd SWOT Analysis / TOWS Matrix

Basic Materials , Misc. Fabricated Products


Neovasc Inc SWOT Analysis / TOWS Matrix

Healthcare , Medical Equipment & Supplies


New Energy Solar SWOT Analysis / TOWS Matrix

Utilities , Electric Utilities


Stride Gaming PLC SWOT Analysis / TOWS Matrix

Services , Recreational Activities


Ipl Plastics SWOT Analysis / TOWS Matrix

Basic Materials , Fabricated Plastic & Rubber


Shandong Nanshan SWOT Analysis / TOWS Matrix

Basic Materials , Metal Mining


Kingboard Copper Foil Holdings Ltd SWOT Analysis / TOWS Matrix

Basic Materials , Misc. Fabricated Products


JVC Kenwood Corp SWOT Analysis / TOWS Matrix

Consumer Cyclical , Audio & Video Equipment


Daishinku Corp SWOT Analysis / TOWS Matrix

Technology , Electronic Instr. & Controls